These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35180141)
21. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Zhang Y; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990 [TBL] [Abstract][Full Text] [Related]
22. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer. Zhong W; Yu Z; Zhan J; Yu T; Lin Y; Xia ZS; Yuan YH; Chen QK Pathol Oncol Res; 2015 Jan; 21(1):83-95. PubMed ID: 24875250 [TBL] [Abstract][Full Text] [Related]
23. Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. Kouri M; Pyrhönen S; Kuusela P J Surg Oncol; 1992 Feb; 49(2):78-85. PubMed ID: 1738240 [TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients. Groblewska M; Mroczko B; Gryko M; Kędra B; Szmitkowski M Folia Histochem Cytobiol; 2010 Dec; 48(4):564-71. PubMed ID: 21478099 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
26. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691 [TBL] [Abstract][Full Text] [Related]
27. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. Holten-Andersen MN; Nielsen HJ; Sørensen S; Jensen V; Brünner N; Christensen IJ Eur J Cancer; 2006 Aug; 42(12):1889-96. PubMed ID: 16809030 [TBL] [Abstract][Full Text] [Related]
28. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer. He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885 [TBL] [Abstract][Full Text] [Related]
29. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
30. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer. Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311 [TBL] [Abstract][Full Text] [Related]
31. Changes in plasma TIMP-1 levels after resection for primary colorectal cancer. Frederiksen C; Lomholt AF; Davis GJ; Dowell BL; Blankenstein MA; Christensen IJ; Brünner N; Nielsen HJ Anticancer Res; 2009 Jan; 29(1):75-81. PubMed ID: 19331135 [TBL] [Abstract][Full Text] [Related]
32. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053 [TBL] [Abstract][Full Text] [Related]
33. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma. Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431 [TBL] [Abstract][Full Text] [Related]
34. Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study. Birgisson H; Nielsen HJ; Christensen IJ; Glimelius B; Brünner N Eur J Cancer; 2010 Dec; 46(18):3323-31. PubMed ID: 20619633 [TBL] [Abstract][Full Text] [Related]
35. TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis. Meng C; Yin X; Liu J; Tang K; Tang H; Liao J PLoS One; 2018; 13(11):e0207039. PubMed ID: 30458003 [TBL] [Abstract][Full Text] [Related]
36. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients]. Grotowski M; Maruszyński M; Piechota W Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841 [TBL] [Abstract][Full Text] [Related]
37. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT? Panagiotidis E; Datseris IE; Rondogianni P; Vlontzou E; Skilakaki M; Exarhos D; Bamias A Nucl Med Commun; 2014 Jun; 35(6):598-605. PubMed ID: 24681767 [TBL] [Abstract][Full Text] [Related]
38. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases. Yang XQ; Chen C; Peng CW; Liu SP; Li Y Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105 [TBL] [Abstract][Full Text] [Related]
39. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer. Wang YR; Yan JX; Wang LN J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941 [TBL] [Abstract][Full Text] [Related]
40. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Yang XQ; Chen C; Wang FB; Peng CW; Li Y Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]